DESOXY | |
---|---|
![]() |
|
![]() |
|
2-(3,5-Dimethoxy-4-methyl-phenyl)-ethylamine |
|
Other names
3,5-Dimethoxy-4-methylphenethylamine |
|
Identifiers | |
CAS number | 63037-49-0 |
ChemSpider | 21106289 ![]() |
ChEMBL | CHEMBL127679 ![]() |
Jmol-3D images | Image 1 |
|
|
|
|
Properties | |
Molecular formula | C11H17NO2 |
Molar mass | 195.26 g/mol |
![]() ![]() ![]() Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
Infobox references |
4-Desoxymescaline, or 4-methyl-3,5-dimethoxyphenethylamine, is a mescaline analogue related to other psychedelic phenethylamines. It is commonly referred to as DESOXY. DESOXY was discovered by Alexander Shulgin and published in his book PiHKAL.
Contents |
The effects of DESOXY vary significantly from mescaline, despite their chemical similarity. Users report an elevated mood and some hallucinations, although nothing as intense as visuals reported on mescaline[citation needed]. There has been some suggestion that the dosage level of 40-120 mg might be too small to achieve mescaline-like effects, but since this compound has undergone only limited human experiments it may be unsafe to increase the dosage.
A typical dosage is within the range of 40-120 mg and lasts 6–8 hours.[1]
In 1970 the Controlled Substances Act placed mescaline into Schedule I in the United States. It is similarly controlled in other nations. Depending on whether or not it is intended for human consumption, 4-desoxymescaline could be considered an analogue of mescaline, under the Federal Analogue Act and similar bills in other countries, making it illegal to manufacture, buy, possess, or distribute without a DEA or related license.
|
|
|